Contact Us

3D Ultrasound/MRI Fusion Biopsy – Highly Targeted Diagnostics for Prostate Cancer

The 3D Ultrasound/MRI Fusion Biopsy for prostate cancer “fuses” detailed MRI scans with live, real-time ultrasound images of the prostate, providing urologists with the capabilities to pinpoint exact prostate cancer location within the prostate gland and better identify the extent of disease. Several studies have demonstrated that this new system provides a higher level of accuracy in diagnosis for patients at risk of prostate cancer.


The Groundbreaking Technology Includes:

Promap- MR

The PROMAP-MR – combines 3D ultrasound and MRI to produce an accurate 3D mapping of biopsy samples within multimodal images.





The PROMAP-US – combines full 3D ultrasound and automatic organ tracking to create, visualize and memorize a 3D map of “target” lesions and biopsy samples.




How 3D Ultrasound/MRI Fusion Biopsy Works

By combining advanced MRI imaging with 3D ultrasound technology, this new biopsy system:

  • Creates a 3D map of the prostate.
  • Identifies suspicious lesions or targets on MRI.
  • A specially trained urologist overlays 3D MRI and 3D ultrasound images in order to get a precise picture and location of suspicious areas of the prostate (also known as “targets”).
  • Accurately guides the biopsy needle into the target lesion. Uniform random biopsies of other areas of the prostate may also be performed, depending upon the clinical circumstances.
  • The computer creates a record of the exact location of each biopsy, which is then stored and available for future use.


Studies show that computer-assisted 3D Ultrasound/MRI Fusion Biopsy provides a more precise way to identify clinically significant prostate cancers. This allows patients access to unique technology that will significantly improve their clinical outcomes.


Who is a Candidate?

Several groups of patients can take advantage of this diagnostic tool including:

  • Men who have a current diagnosis of prostate cancer and have chosen Active Surveillance or watchful waiting (which typically requires periodic biopsies)
  • Men who have a persistently rising PSA level despite having a previous 2D (2 Dimensional) Transrectal Ultrasound (TRUS)-guided biopsy and prostate needle biopsy which was negative for cancer
  • Men who are found on traditional 2D TRUS-guided biopsy to have cells that are abnormal but cannot be confirmed as cancer
  • Men with a newly identified elevated PSA
  • Men previously treated for prostate cancer with radiation therapy or cryosurgery who have a rising PSA that suggests a possible recurrence of cancer in the prostate gland.
Talk to your doctor about the 3D Ultrasound/MRI Fusion Biopsy to see if you are a candidate for this advanced diagnostic procedure for prostate cancer.
Contact Us

Appointments & Information

*If this is an emergency, please call 911 immediately.

Please provide your email address and phone number and a Tennessee Urology representative will contact you shortly to assist with your question or issue.

Monday–Friday, 8:30 a.m. to 4:30 p.m.

Contact Us